(Q36441502)

14 August 2017

1 reference

title

Probiotics: their role in the treatment and prevention of disease (English)

1 reference

14 August 2017

0 references

1 reference

2

0 references

author name string

Shira Doron

series ordinal

1

1 reference

PubMed ID

16597207

14 August 2017

Sherwood L Gorbach

series ordinal

2

1 reference

14 August 2017

1 April 2006

1 reference

Expert Review of Anti-infective Therapy

14 August 2017

1 reference

14 August 2017

4

1 reference

14 August 2017

2

1 reference

14 August 2017

261-275

1 reference

Microbial-gut interactions in health and disease. Probiotics.

14 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Evaluation of probiotic treatment in a neonatal animal model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Antimicrobial substance from a human Lactobacillus strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Production of a Broad Spectrum Antimicrobial Substance by Lactobacillus reuteri

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Effects of prebiotics on the immune response to vaccination in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Increased enterocyte production in gnotobiotic rats mono-associated with Lactobacillus rhamnosus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

The complete genomes of Lactobacillus plantarum and Lactobacillus johnsonii reveal extensive differences in chromosome organization and gene content

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Lactobacillus bacteremia and endocarditis: review of 45 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Lactobacillemia--report of nine cases. Important clinical and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Lactobacillus acidophilus as a dietary adjunct for milk to aid lactose digestion in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Probiotics in the management of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Prevention of travellers' diarrhoea by Lactobacillus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Ulcerative colitis and Escherichia coli with adhesive properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Effects of fermentation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Assessment of mucosal inflammation and blood flow in response to four weeks' intervention with probiotics in patients operated with a J-configurated ileal-pouch-anal-anastomosis (IPAA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Outcome of four weeks' intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.261

21 January 2018

Identifiers

DOI

10.1586/14787210.4.2.261

1 reference

14 August 2017

1 reference

PubMed ID

16597207